Brandi Zofkie is the Associate Vice President of Lung Bioengineering Inc. (LBE), a subsidiary of United Therapeutics and the first centralized ex vivo lung perfusion service model in the United States. Overseeing operations and commercial functions as one of world’s first Certified Ex Vivo Specialists, Brandi Zofkie is a proven leader known for excelling at both strategy and execution.
As AVP, Brandi manages the daily intricacies of clinical operations across multiple LBE facilities while simultaneously spearheading the company’s commercial growth model. This includes leading the design and development of LBE’s customer engagement strategy and channels, all of which are geared towards its mission to increase donor lung utilization rates. Brandi and her team work alongside transplant centers, organ procurement organizations (OPOs) and government agencies to deliver on this mission and more broadly transform the field of transplantation as we know it today.
Earlier in her career, Brandi was a Certified Procurement Transplant Coordinator (CPTC) at Indiana Donor Network where she medically managed organ donor patients in the ICU. As a public health professional, Brandi focuses on addressing health disparities and promoting community health. She believes that utilizing EVLP to assess organ function over extended periods of time will greatly expand the number of lungs available for transplant thus eliminating deaths on the lung waitlist and promising a new era in transplantation.
Brandi holds a BA in Biochemistry from Capital University, a MPH from A.T. Still University and a MSBS in Human Donation Science from the College of Medicine at the University of Toledo. Brandi is an active member of The International Society for Heart & Lung Transplantation (ISHLT), the North American Transplant Coordinators Organization (NATCO), and is a credentialed CPTC through the American Board for Transplant Certification.
